Janssen Announces U.S. FDA Accelerated Approval for Sirturo (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis

TITUSVILLE, NJ, August 9, 2019— The Janssen Pharmaceutical Companies of Johnson& Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Sirturo (bedaquiline) tablets as part of combination...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news